Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 24;9(5):566-583.
doi: 10.1002/mdc3.13436. eCollection 2022 Jul.

Skin Conditions and Movement Disorders: Hiding in Plain Sight

Affiliations
Review

Skin Conditions and Movement Disorders: Hiding in Plain Sight

Kristina Kulcsarova et al. Mov Disord Clin Pract. .

Abstract

Skin manifestations are well-recognized non-motor symptoms of Parkinson's disease (PD) and other hypokinetic and hyperkinetic movement disorders. Skin conditions are usually well visible during routine clinical examination and their recognition may play a major role in diagnostic work-up. In this educational review we: (1) briefly outline skin conditions related to Parkinson's disease, including therapy-related skin complications and their management; (2) discuss the role of skin biopsies in early diagnosis of PD and differential diagnosis of parkinsonian syndromes; and focus more on areas which have not been reviewed in the literature before, including (3) skin conditions related to atypical parkinsonism, and (4) skin conditions related to hyperkinetic movement disorders. In case of rare hyperkinetic movement disorders, specific dermatological manifestations, like presence of angiokeratomas, telangiectasias, Mongolian spots, lipomas, ichthyosis, progeroid skin changes and others may point to a very specific group of disorders and help guide further investigations.

Keywords: atypical parkinsonism; hyperkinetic; movement disorders; skin; skin biopsy.

PubMed Disclaimer

Conflict of interest statement

This work was supported by the Operational Programme Integrated Infrastructure, funded by the ERDF under No. ITMS2014+:313011 V455 for KK, JB and MS. The authors declare that there are no conflicts of interest relevant to this work.

Figures

FIG 1
FIG 1
Skin changes in Parkinson's disease. (A) Seborrheic dermatitis, (B) Rosacea, (C) Bullous pemphigoid.
FIG 2
FIG 2
Skin changes in hyperkinetic movement disorders. (A) Freckle‐like pigmentary changes and (B) Skin xerosis on left elbow in a patient with biallelic ERCC4 variants causing Xeroderma pigmentosum type F presenting also with generalized chorea, ataxia and mild cognitive problems, (C) Cutaneous telangiectasias (arrow) in a patient with biallelic ATM variants, (D) Incontinentio pigmenti, (E) Hypomelanosis of Ito (hypomelanotic streak on the left leg—black arrows), (F) Mongolian spots in a child with GM1‐gangliosidosis, (G) Angiokeratoma (adapted with permissions from Cuestas et al. 2019 97 ), (H) Hypertrichosis in a child with biallelic SURF1 variants, (I) Erythema marginatum, (J) Malar rash in lupus erythematosus.
FIG 3
FIG 3
Skin changes in hyperkinetic movement disorders. (A) Classical pellagra dermatitis over sun‐exposed area of the lower limb with a clear cut‐off at the margins of clothing (adapted with permissions from Madhyastha et al. 2020), (B) Ichthyosis, (C) self‐injurious behavior—artificial skin changes, (D) Self‐injurious behavior—lip biting in antiNMDAR encephalitis, (E) Chilblain lesions in Aicardi‐Gutieres syndrome (adapted with premissions from Videira et al. 2020) (F) Mastocytosis, (G) Tendon xanthomas in Cerebrotendinous xanthomatosis (courtesy of Dr. Paldaufova, Dr. Serdahely, Dept. of Neurology, Skalica, Slovakia), (H) Periorbital xanthelasma in Erdheim‐Chester disease (adapted with permissions from Chasset et al. 2016), (I) Abdominal skin ulcerations in Behçet disease (adapted with permissions from Scherrer et al. 2017).

Similar articles

Cited by

References

    1. Skorvanek M, Bhatia KP. The skin and Parkinson's Disease: Review of clinical, diagnostic, and therapeutic issues. Mov Disord Clin Pract 2016;4:21–31. - PMC - PubMed
    1. Niemann N, Billnitzer A, Jankovic J. Parkinson's disease and skin. Parkinsonism Relat Disord 2021;82:61–76. - PubMed
    1. Berkovic SF, Andermann F, Shoubridge EA, et al. Mitochondrial dysfunction in multiple symmetrical lipomatosis. Ann Neurol 1991;29:566–569. - PubMed
    1. Mohrenschlager M, Braun‐Falco M, Ring J, Abeck D. Fabry Disease: Recognition and management of cutaneous manifestations. Am J Clin Dermatol 2003;4:189–196. - PubMed
    1. Gordon LB, Rothman FG, López‐Otín C, Misteli T. Progeria: A paradigm for translational medicine. Cell 2014;156:400–407. - PMC - PubMed

LinkOut - more resources